Mounjaro stands as an exceptionally effective treatment for weight loss, demonstrating in clinical trials the potential to facilitate approximately 20% reduction in body weight. It represents the newest advancement in GLP-1 weight loss injections, designed for individuals with a body mass index (BMI) of over 30. The medication, which includes the active compound tirzepatide, is a trademarked product of Eli Lilly is mounjaro available in the uk. In the United States, it’s marketed as Zepbound, whereas it’s introduced in the UK as Mounjaro, requiring a once-weekly subcutaneous injection.

How does Mounjaro function?

At its core, Mounjaro’s active component, tirzepatide, belongs to a category of medications known as GLP-1 agonists. These drugs play a pivotal role in regulating hunger signals, a process naturally initiated by the intestines post-meal. Mimicking GLP-1, Mounjaro effectively moderates appetite, enhancing feelings of fullness and reducing hunger. This mechanism supports decreased caloric intake and weight loss, especially when paired with a calorie-reduced diet, amplifying Mounjaro’s effectiveness.

The MHRA has authorised the diabetes drug Mounjaro (tirzepatide) for weight management and weight loss. For the first time in the UK, obese individuals and those overweight with weight-related health issues now have access to Mounjaro, previously utilised for Type 2 diabetes, to assist in managing their weight and supporting weight loss. It is administered via an injection under the skin in the abdominal area, thigh, or upper arm, and should be used alongside a reduced-calorie diet and increased physical activity.

Offering Mounjaro online in the UK, Semapen enables you to take charge of your health and well-being with enhanced ease and convenience, fostering a supportive environment for sustainable lifestyle changes.

After completing an online assessment and qualifying, you can order your medication online with just a few clicks. Additionally, you’ll receive a complimentary Withings® Body smart scale (valued at £60), connected to our bespoke SemaPen app via the cloud, providing you and our support team with real-time insights into your progress.

You’ll also gain exclusive access to personalised support from obesity care experts. Our team of dietitians, nurses, and psychologists, utilising SemaPen’s technology, will ensure you remain on track towards achieving your goals. Should you have any questions, the Semapen FAQ page is readily available for swift answers.

As a part of the Phoenix Health Group (the only private bariatric provider endorsed by the NHS and rated 5-star by Trustpilot), Semapen assists individuals on their weight loss journey, making weight loss more attainable.

What is Mounjaro (Trizeptide)?

Mounjaro stands as an exceptionally effective treatment for weight loss, demonstrating in clinical trials the potential to facilitate approximately 20% reduction in body weight. It represents the newest advancement in GLP-1 weight loss injections, designed for individuals with a body mass index (BMI) of over 30. The medication, which includes the active compound tirzepatide, is a trademarked product of Eli Lilly. In the United States, it’s marketed as Zepbound, whereas it’s introduced in the UK as Mounjaro, requiring a once-weekly subcutaneous injection.

How does Mounjaro function?

At its core, Mounjaro’s active component, tirzepatide, belongs to a category of medications known as GLP-1 agonists. These drugs play a pivotal role in regulating hunger signals, a process naturally initiated by the intestines post-meal. Mimicking GLP-1, Mounjaro effectively moderates appetite, enhancing feelings of fullness and reducing hunger. This mechanism supports decreased caloric intake and weight loss, especially when paired with a calorie-reduced diet, amplifying Mounjaro’s effectiveness.

The MHRA has authorised the diabetes drug Mounjaro (tirzepatide) for weight management and weight loss. For the first time in the UK, obese individuals and those overweight with weight-related health issues now have access to Mounjaro, previously utilised for Type 2 diabetes, to assist in managing their weight and supporting weight loss. It is administered via an injection under the skin in the abdominal area, thigh, or upper arm, and should be used alongside a reduced-calorie diet and increased physical activity.

Offering Mounjaro online in the UK, Semapen enables you to take charge of your health and well-being with enhanced ease and convenience, fostering a supportive environment for sustainable lifestyle changes.

After completing an online assessment and qualifying, you can order your medication online with just a few clicks. Additionally, you’ll receive a complimentary Withings® Body smart scale (valued at £60), connected to our bespoke SemaPen app via the cloud, providing you and our support team with real-time insights into your progress.

You’ll also gain exclusive access to personalised support from obesity care experts. Our team of dietitians, nurses, and psychologists, utilising SemaPen’s technology, will ensure you remain on track towards achieving your goals. Should you have any questions, the Semapen FAQ page is readily available for swift answers.

As a part of the Phoenix Health Group (the only private bariatric provider endorsed by the NHS and rated 5-star by Trustpilot), Semapen assists individuals on their weight loss journey, making weight loss more attainable.

What is Mounjaro (Trizeptide)?

Mounjaro stands as an exceptionally effective treatment for weight loss, demonstrating in clinical trials the potential to facilitate approximately 20% reduction in body weight. It represents the newest advancement in GLP-1 weight loss injections, designed for individuals with a body mass index (BMI) of over 30. The medication, which includes the active compound tirzepatide, is a trademarked product of Eli Lilly. In the United States, it’s marketed as Zepbound, whereas it’s introduced in the UK as Mounjaro, requiring a once-weekly subcutaneous injection.

How does Mounjaro function?

At its core, Mounjaro’s active component, tirzepatide, belongs to a category of medications known as GLP-1 agonists. These drugs play a pivotal role in regulating hunger signals, a process naturally initiated by the intestines post-meal. Mimicking GLP-1, Mounjaro effectively moderates appetite, enhancing feelings of fullness and reducing hunger. This mechanism supports decreased caloric intake and weight loss, especially when paired with a calorie-reduced diet, amplifying Mounjaro’s effectiveness.

The MHRA has authorised the diabetes drug Mounjaro (tirzepatide) for weight management and weight loss. For the first time in the UK, obese individuals and those overweight with weight-related health issues now have access to Mounjaro, previously utilised for Type 2 diabetes, to assist in managing their weight and supporting weight loss. It is administered via an injection under the skin in the abdominal area, thigh, or upper arm, and should be used alongside a reduced-calorie diet and increased physical activity.

Offering Mounjaro online in the UK, Semapen enables you to take charge of your health and well-being with enhanced ease and convenience, fostering a supportive environment for sustainable lifestyle changes.

After completing an online assessment and qualifying, you can order your medication online with just a few clicks. Additionally, you’ll receive a complimentary Withings® Body smart scale (valued at £60), connected to our bespoke SemaPen app via the cloud, providing you and our support team with real-time insights into your progress.

You’ll also gain exclusive access to personalised support from obesity care experts. Our team of dietitians, nurses, and psychologists, utilising SemaPen’s technology, will ensure you remain on track towards achieving your goals. Should you have any questions, the Semapen FAQ page is readily available for swift answers.

As a part of the Phoenix Health Group (the only private bariatric provider endorsed by the NHS and rated 5-star by Trustpilot), Semapen assists individuals on their weight loss journey, making weight loss more attainable.